STROMABLAST
Live / Allowed — Notice of allowance issued (as of 21 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99045443
- Mark type
- Stylized text
- Filed
- 18 Feb 2025
- Published for opposition
- 26 Aug 2025
- Attorney of record
- Yi LIU
Goods and services
- Class 042 — Scientific and technological services: Research on the subject of pharmaceuticals; Pharmaceutical research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Research and development of pharmaceutical preparations for treating malignant tumours; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Scientific research in the field of pharmaceuticals and biotechnology; Medical and scientific research in the field of cancer treatment and diagnosis; Biotechnology research; Scientific research for medical purposes in the area of cancerous diseases; Biological research; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Providing laboratory research services in the field of gene expression, namely, cancer biology; Biomedical research services; Research and development of vaccines and medicines; Laboratory research services relating to pharmaceuticals; Research and development services in the field of antibodies; Medical research in the field of oncology; Scientific research in the field of genetics and genetic engineering; Medical research services in the field of cancer; Drug screening for scientific research purposes; Research in the field of bioengineering; Research in the field of synthetic biology; Cell culture services for scientific and research purposes, for others; Research in the field of plant genetic engineering technology; Research and development of siRNA drugs; Medical research laboratory services in the field of oncology; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Biochemical research and development services; Research and development services in the field of biotechnology; Research and development services relating to medicines; Research and development of medicines; Research and development services in the field of medical preparations; Research in the field of bioinformatics; Research in the field of immunodeficiency
Owner
- Simcere Zaiming, Inc., Cambridge, MA, US
- Simcere Zaiming, Inc., Cambridge, MA, US
Prosecution history
- 25 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jul 2025 — ASSIGNED TO EXAMINER
- 15 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 18 Feb 2025 — NEW APPLICATION ENTERED